Genevieve Loos

Clermont-ferrand, FR 
Clinical Trials:Currently Recruiting for 1 Trial
Clermont-ferrand, FR 

Overview

Genevieve Loos practices practicing medicine in Clermont-ferrand, France.

Her clinical expertise encompasses Prostate Cancer, Muscle Invasive Bladder Cancer, Penile Cancer, and Prostatectomy.

She is actively involved in clinical research, co-authoring 19 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Clermont-ferrand, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase II Study Assessing Stereotactic Radiotherapy in Therapeutic Strategy of Oligoprogressive Renal Cell Carcinoma Metastases
A Phase II Study Assessing Stereotactic Radiotherapy in Therapeutic Strategy of Oligoprogressive Renal Cell Carcinoma Metastases
Enrollment Status: Recruiting
Publish Date: January 13, 2026
Intervention Type: Radiation
Study Drug: Pursuit of ongoing systemic treatment
Study Phase: Phase 2
Phase I/II Multi-center Study Evaluating the Efficacy of Repeat Stereotactic Radiation in Patients With Intraprostatic Tumor Recurrence After External Radiation Therapy
Phase I/II Multi-center Study Evaluating the Efficacy of Repeat Stereotactic Radiation in Patients With Intraprostatic Tumor Recurrence After External Radiation Therapy
Enrollment Status: Active_not_recruiting
Publish Date: December 20, 2024
Intervention Type: Radiation
Study Phase: Not Applicable
View 1 Less Clinical Trial

19 Total Publications

Re: Riccardo Bertolo, Antonio Luigi Pastore, Paolo Verze, et al. Real-World Burden and Management of Late Genitourinary toxicity After Prostate Radiotherapy: Insights from IRRADIaTE, the Italian Registry of Radiotherapy-Associated Disorders and Urological Treatment & Evaluation. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2026.01.005.
Re: Riccardo Bertolo, Antonio Luigi Pastore, Paolo Verze, et al. Real-World Burden and Management of Late Genitourinary toxicity After Prostate Radiotherapy: Insights from IRRADIaTE, the Italian Registry of Radiotherapy-Associated Disorders and Urological Treatment & Evaluation. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2026.01.005.
Journal: European urology oncology
Published: February 01, 2026

Frequently Asked Questions about Genevieve Loos

Is Genevieve Loos a top-rated expert for Prostate Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Genevieve Loos is classified as an Experienced expert for Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Genevieve Loos participate in research or clinical trials?

Yes. Genevieve Loos has published 19 articles and abstracts on conditions like Prostate Cancer. You can view a list of Genevieve Loos's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Loos's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile